Upgrade to SI Premium - Free Trial

BioXcel Therapeutics (BTAI) PT Raised to $80 at BofA Securities

April 6, 2022 11:09 AM
BofA Securities analyst Geoff Meacham ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles